The 6th CIIE has arrived as scheduled, and this year's medical device and healthcare exhibition area has also attracted the participation of global multinational pharmaceutical giants.

On January 26, the information released by the National Drug Administration (NMPA) showed that Smeaglutide Tablets under Novo Nordisk (China) Pharmaceutical Co., Ltd. was approved for listing to trea ...

Reporters learned from the State Food and Drug Administration on January 26 that Novo Nordisk Megglutide Tablets have been approved by the State Food and Drug Administration (NMPA) for marketing to t ...

[Oral Smeglutide was approved for marketing in China] On January 26, Novo Nordisk Smeglutide tablets were approved for marketing by the National Drug Administration (NMPA) for the treatment of type 2 ...

A new study shows that Wegovy (mainly composed of smeglutide), the "weight-loss magic drug" of Novo Nordisk, can not only lose weight, but also benefit the health of patients with diabetes and heart ...

The importance of diabetes management and prevention is self-evident, and diabetes prevention and treatment has been included in the Health China Special Action. As a world leading medical and health ...